Scanogen is a molecular diagnostic company developing systems to read the biomolecular information of body fluids with the goal of improving health care. The Company has developed Single MOLecule Tethering (SMOLT), a proprietary technology for rapid and ultra-sensitive detection of biomolecules. The Company is using this technology to develop a simple-to-use and sample-to-answer diagnostic platform. Scanogen has received NIH grants totaling $9.5 million to develop its diagnostic assays and it is currently focused on two areas: Point-of-care diagnosis and bloodstream infection detection.
Company’s Keywords:
dna detection, dna genotyping, early diagnosis of cancer, infectious disease detection
6
medical devices
310000
Gmail, Google Apps, GoDaddy Hosting, Apache, Bootstrap Framework, Mobile Friendly, Google Tag Manager
2011
Your request has been submitted successfully.
Own or work here?